KK-3910
- Generic Name
- KK-3910
Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension
Phase 1
Recruiting
- Conditions
- Healthy Volunteers Essential Hypertension
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT06823947
- Locations
- 🇯🇵
Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath